# Novus Biotechnology Fund 1, L.P. — Form D/A

Novus Biotechnology Fund 1, L.P. of Portage, MI, a company, filed a Form D amendment with the SEC on 2015-07-02. The offering totals $20.0M, of which $2.0M was reported sold. Industry: Investing.

## Offering

- Filed: 2015-07-02
- Form: D/A
- Accession: 0001622840-15-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $2.0M
- Remaining: $18.0M
- Minimum investment: $100K
- Investors: 17
- Date of first sale: 2014-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228209

## Issuer

- Name: Novus Biotechnology Fund 1, L.P.
- CIK: 0001622840
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1151 W. Milham Ave, Portage, MI, 49081
- Phone: 269-207-0656

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth John Easton | Executive Officer | Portage, MI |
| John John Keller | Executive Officer | Portage, MI |
| Kevin McLeod | Executive Officer | Portage, MI |
| Matthew John Milanowski | Executive Officer | Portage, MI |
| Frank Saltiel | Executive Officer | San Jose, CA |
| Gregory Schultz | Executive Officer | Portage, MI |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-11-13](https://search.stillhousedata.com/formd/0001622840-14-000001) | D | $20.0M | $2.0M |

## More

- [CIK 1622840 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1622840&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001622840-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.